Legal News

Regulators discuss the importance of real-world data in finding treatment for coronavirus (COVID-19)

Published on: 08 April 2020
Published by LNB News

LNB News 08/04/2020

Document Information

Issue Date: 08 April 2020

Published Date: 08 April 2020

Jurisdiction(s): United Kingdom

Article summary

In a dedicated coronavirus (COVID-19) workshop, international medical regulators, under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA), discussed how data elaborated in clinical practice could complement evidence from clinical trials to develop treatment for coronavirus. Participants recognised the need to combine observational studies of real-world data with clinical trials to improve regulatory processes for development of treatment and prevention of the virus and to address gaps in knowledge.

Popular documents